All In Biotech

Drug Trial Radar · NCT00030966

Safety and Efficacy of Natalizumab in Combination With Avonex in the Treatment of Multiple Sclerosis

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Determine the Safety and Efficacy of Natalizumab, When Added to Avonex® (Interferon Beta-1a), in Subjects With Relapsing-Remitting Multiple Sclerosis

Last checked: Nov 20, 2026Latest source record: Jun 18, 2009 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 1,200 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,200

Actual

Start

Jan 2002

Primary completion

Apr 2005

Study completion Dec 2005

Sponsor

Lead sponsor
BiogenBiogen (BIIB)
Sponsor type
Industry
Collaborators
Elan Pharmaceuticals
First posted
Feb 18, 2002

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 55 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine if natalizumab in combination with AVONEX is safe and effective in delaying progression of individuals diagnosed with relapsing remitting Multiple Sclerosis (MS).

Conditions

  • Multiple Sclerosis, Relapsing-Remitting

Interventions

  • NatalizumabDrug

    Natalizumab, 300 mg, monthly IV infusion for up to 116 weeks.

  • PlaceboDrug

    Placebo monthly infusion for up to 116 weeks.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Primary objectives of this study are to determine if natalizumab is effective in reducing the rate of clinical relapse at 1 year and in slowing the progression of disability at 2 years as measured by EDSS.Time frame: 1 year and 2 years

Locations

88 sites in 7 countries. Site status is shown where the registry gives one.

  • University of Alabama-Birmingham, Department of Neurology

    Birmingham, Alabama

  • Phoenix Neurological Associates, Ltd.

    Phoenix, Arizona

  • University of Arkansas For Medical Sciences

    Little Rock, Arkansas

  • University of California - Irvine

    Irvine, California

  • USC MS Comprehensive Care Center

    Los Angeles, California

  • Kaiser-Permanente Medical Center

    Redwood City, California

  • MS Center at UCSF

    San Francisco, California

  • Healthsouth Rehabilitation Hospital

    Colorado Springs, Colorado

  • University of Colorado MS Center

    Denver, Colorado

  • Griffin Hospital

    Derby, Connecticut

  • Georgetown Univesity Hospital, Research Pharmacy

    Washington D.C., District of Columbia

  • George Washington University MS Center

    Washington D.C., District of Columbia

  • North Ridge NeuroScience Center

    Fort Lauderdale, Florida

  • Maitland Neurology

    Maitland, Florida

  • University of Miami, Department of Neurology

    Miami, Florida

  • The Multiple Sclerosis Center of Atlanta

    Atlanta, Georgia

  • Marietta Neurological Associates

    Marietta, Georgia

  • Northwestern University, Department of Neurology

    Chicago, Illinois

  • Rush-Presbyterian St. Luke's Medical Center

    Chicago, Illinois

  • Alexian Brothers Center for Clinical Research

    Elk Grove Village, Illinois

  • Loyola Medical Center

    Maywood, Illinois

  • Consultants in Neurology Northbrook

    Northbrook, Illinois

  • Springfield Clinic Neuroscience Institute

    Springfield, Illinois

  • Indiana University Medical Center

    Indianapolis, Indiana

  • Mercy Hospital Outpatient Pharmacy

    Des Moines, Iowa

  • LSU Neurolgoy Clinic in New Orleans

    New Orleans, Louisiana

  • Maine Neurology

    Scarborough, Maine

  • University of Maryland Hospital, Department of Neurology

    Baltimore, Maryland

  • Brigham and Women's Hospital

    Boston, Massachusetts

  • University of Massachusetts Memorial Medical Center

    Worcester, Massachusetts

  • Henry Ford Hospital

    Detroit, Michigan

  • Michigan State University MS Clinic

    East Lansing, Michigan

  • Michigan Institute for Neurological Disorders

    Farmington Hills, Michigan

  • Noran Neurological Clinic

    Minneapolis, Minnesota

  • University of Mississippi Medical Center

    Jackson, Mississippi

  • St. John's Mercy Medical Center

    St Louis, Missouri

  • Bernard W. Gimbel MS Center

    Teaneck, New Jersey

  • Upstate Clinical Research, LLC

    Albany, New York

  • Albany Medical Center

    Albany, New York

  • Maimonides Medical Center, Division of Neurology

    Brooklyn, New York

Showing 40 of 88 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.